In this video, Steven Grinspoon, MD, talks about the overall take-home messages from his session Mechanisms and Treatments for Steatosis in HIV, including what's next for research on this topic.
In this video, Steven Grinspoon, MD, talks about why treatments for steatosis in HIV are important to study, including some reasons why most studies in nonalcoholic fatty liver disease (NAFLD) do not...
In this video, Steven Grinspoon, MD, speaks about effective treatments of steatosis in patients with HIV, including whether tesamorelin could decrease liver fat in men and women living with HIV and...
In this video, Steven Grinspoon, MD, talks about the association between HIV and Steatosis and why patients with HIV are at an increased risk of steatosis.
In this video, Steven Grinspoon, MD, talks about his session Mechanisms and Treatments of Steatosis in HIV at the Conference on Retroviruses and Opportunistic Infections 2021, including the reasons why...
He discusses his research in virology and how his team is working to produce better vaccines through understanding the immunology of helper T cells, germinal centers, and the human-naïve B-cell...
In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
Jane Yee, MD, answers our questions about the prevention of COVID-19 among patients with HIV, the risks these patients may face if they are exposed to the novel coronavirus, and the importance of ensuring...
He discusses his latest research on the effects of tesamorelin use on non-alcoholic fatty liver disease (NAFLD) in patients with HIV, how the increase in obesity among patients with HIV affects the risk for...
